Log in to save to my catalogue

Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabo...

Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2653544307

Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism

About this item

Full title

Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-04, Vol.17 (4), p.e0266601-e0266601

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of 10%. A stagnant high mortality rate over the last decades highlights the need for innovative therapeutic approaches. Pancreatic tumors pursue an altered metabolism in order to maintain energy generation under low nutrient influx and hypoxic conditions. Tar...

Alternative Titles

Full title

Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2653544307

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2653544307

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0266601

How to access this item